Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 4, 2019, Pages

  Salati, Jennifer A ^a   Leathersich, Sebastian J ^b   Williams, Myfanwy J ^c   Cuthbert, Anna ^c   Tolosa, Jorge E ^a,d,e,f,g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b KING EDWARD MEMORIAL HOSPITAL   (Australia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d Global Network for Perinatal and Reproductive Health   (United States)

^e UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^f FUNDARED MATERNA ^*  (Colombia)

^g St Luke's University Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOMETRINE; ERGOT ALKALOID; HEMOGLOBIN; OXYTOCIN; PLACEBO;

ALL CAUSE MORTALITY; BLOOD TRANSFUSION; CESAREAN SECTION; CHEMOPROPHYLAXIS; CHILDBIRTH; CLINICAL OUTCOME; DIASTOLIC BLOOD PRESSURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; LABOR MANAGEMENT; LABOR STAGE 3; MATERNAL MORTALITY; PATIENT CARE; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VAGINAL DELIVERY; FEMALE; META ANALYSIS; OBSTETRIC DELIVERY; ODDS RATIO; PREGNANCY; STATISTICS AND NUMERICAL DATA;

BLOOD TRANSFUSION; DELIVERY, OBSTETRIC; FEMALE; HUMANS; LABOR STAGE, THIRD; ODDS RATIO; OXYTOCIN; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 85064921760     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001808.pub3.     Document Type: Review

References (119)

1. Abdel-Aleem H, Singata M, Abdel-Aleem M, Mshweshwe N, Williams X, Hofmeyr GJ. Uterine massage to reduce postpartum hemorrhage after vaginal delivery. International Journal of Gynecology & Obstetrics 2010;111(1):32–6.
2. Adhikari S, Rana A, Bista KD. Active management of third stage of labour: comparison between prophylactic intramuscular methylergometrine and intramuscular oxytocin. Nepal Journal of Obstetrics and Gynaecology 2007; 2(2):24–8.
3. Bader W, Ast S, Hatzmann W. The significance of acupuncture in the third stage of labour. Deutsche Zeitschrift fur Akupunktur 2000;43:264–8.
4. Bader W, Ast S, Reinehr J, Hackmann J, Hatzmann W. Oxytocin versus Akupunktur in der Plazentarperiode-eine prospektiv randomisierte Studie [abstract]. Geburtshilfe und Frauenheilkunde 2000;60 Suppl 1:S73.
5. Bonham DG. Intramuscular oxytocics and cord traction in third stage of labour. Brtish Medical Journal 1963;2:1620–3.
6. Boopathi A, Nayak SR, Rao A, Rao B. Oxytocin versus methylergometrine in the active management of third stage of labour. Open Journal of Obstetrics and Gynecology 2014;4: 666–71.
7. De Groot AN, Van Roosmalen J, Van Dongen PW, Borm GF. A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage. Acta Obstetricia et Gynecologica Scandinavica 1996;75:464–8.
8. Dhananjaya BS, Charishma S. Comparative study of efficacy and safety of intramuscular oxytocin with intramuscular methylergometrine in the active management of third stage of labour. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2014;5(3):734–9.
9. Ezeama CO, Eleje GU, Ezeama NN, Igwegbe AO, Ikechebelu JI, Ugboaja JO, et al. A comparison of prophylactic intramuscular ergometrine and oxytocin for women in the third stage of labor. International Journal of Gynecology and Obstetrics 2014;124(1):67–71.
10. Francis HH, Miller JM, Porteous CR. Clinical trial of an oxytocin-ergometrine mixture. Australian & New Zealand Journal of Obstetrics and Gynaecology 1965;5:47–51.
11. Fugo NW, Dieckmann WJ. A comparison of oxytocic drugs in the management of the placental stage. American Journal of Obstetrics and Gynecology 1958;76:141–6.
12. Ilancheran A, Ratnam SS. Effect of oxytocics on prostaglandin levels in the third stage of labour. Gynecologic and Obstetric Investigation 1990;29:177–80.
13. Jago AA, Ezechi OC, Achinge GI, Okunlola MA. Effect of oxytocics on the blood pressure of normotensive Nigerian parturients. Journal of Maternal-Fetal & Neonatal Medicine 2007;20(9):703–5.
14. Jerbi M, Hidar S, Elmoueddeb S, Chaieb A, Khairi H. Oxytocin in the third stage of labor. International Journal of Gynecology & Obstetrics 2007;96(3):198–9.
15. McGinty LB. A study of the vasopressor effects of oxytocics when used intravenously in the third stage of labour. Western Journal of Surgery 1956;64:22–8.
16. Modi V, Goel JK, Kashyap A, Arya SB, Kar J, Goel R. Active management of third stage of labor: A comparison of various uterotonic. Journal of South Asian Federation of Obstetrics and Gynaecology-SAFOG 2014;6(3):151–5.
17. Moodie JE, Moir DD. Ergometrine, oxytocin and extradural analgesia. British Journal of Anaesthesia 1976;48:571–4.
18. Nordstrom L, Fogelstam K, Fridman G, Larsson A, Rydhstroem H. Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. British Journal of Obstetrics and Gynaecology 1997;104:781–6. ji 2008 {published data only}
19. Orji E, Agwu F, Loto O, Olaleye O. A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor. International Journal of Gynecology & Obstetrics 2008;101(2):129–32.
20. Pierre F, Mesnard L, Body G. For a systematic policy of iv oxytocin inducted placenta deliveries in a unit where a fairly active management of third stage of labour is yet applied: results of a controlled trial. European Journal of Obstetrics & Gynecology and Reproductive Biology 1992;43:131–5.
21. Poeschmann RP, Doesburg WH, Eskes TK. A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour. British Journal of Obstetrics and Gynaecology 1991;98:528–30.
22. Saito K, Haruki A, Ishikawa H, Takahashi T, Nagase H, Koyama M, et al. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage. Journal of Obstetrics and Gynaecology Research 2007;33(3):254–8.
23. Singh G, Radhakrishnan G, Guleria K. Comparison of sublingual misoprostol, intravenous oxytocin, and intravenous methylergometrine in active management of the third stage of labor. International Journal of Gynecology & Obstetrics 2009;107(2):130–4.
24. Sorbe B. Active pharmacologic management of the third stage of labor. A comparison of oxytocin and ergometrine. Obstetrics & Gynecology 1978;52:694–7.
25. Vaughan Williams CA, Johnson A, Ledward R. A comparison of central venous pressure changes in the third stage of labour following oxytocic drugs and diazepam. Journal of Obstetrics and Gynaecology of the British Commonwealth 1974;81:596–9.
26. Barbaro CA, Smith GO. Clinical trial of SE505-a new oxytocic mixture. Australian and New Zealand Journal of Obstetrics and Gynaecology 1961;1:147–50.
27. Boucher M, Nimrod C, Tawagi G. Carbetocin IM injection vs oxytocin IV infusion for prevention of postpartum hemorrhage in women at risk following vaginal delivery. American Journal of Obstetrics and Gynecology 2001;185(6 Pt 2):A494.
28. ∗ Boucher M, Nimrod CA, Tawagi GF, Meeker TA, Rennicks, White RE, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial. Journal of Obstetrics & Gynaecology Canada: JOGC 2004;26 (5):481–8.
29. Dickinson JE, Doherty DA. Optimization of third-stage management after second-trimester medical pregnancy termination. American Journal of Obstetrics and Gynecology 2009;201(3):303.e1–7.
30. Docherty PW, Hooper M. Choice of an oxytocic agent for routine use at delivery. Journal of Obstetrics and Gynaecology 1981;2:60.
31. Dommisse J. The routine use of oxytocic drugs in the third stage of labour [letter]. South African Medical Journal 1980; 46:549.
32. Dumoulin JG. A reappraisal of the use of ergometrine. Journal of Obstetrics and Gynaecology 1981;1:178–81.
33. Friedman EA. Comparative clinical evaluation of postpartum oxytocics. Journal of Obstetrics and Gynecology 1957;73:1306–13.
34. Gerstenfeld T, Wing D. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery. American Journal of Obstetrics and Gynecology 2001;185:878–82.
35. Hacker NF, Biggs JS. Blood pressure changes when uterine stimulants are used after normal delivery. British Journal of Obstetrics Gynaecology 1979;86:633–6.
36. Hoffman M, Castagnola D, Naqvi F. A randomized trial of active versus expectant management of the third stage of labor [abstract]. American Journal of Obstetrics and Gynecology 2006;195(6 Suppl 1):S107.
37. Hoffman M, Naqvi F, Sciscione A. A randomized trial of active versus expectant management of the third stage of labor. American Journal of Obstetrics and Gynecology 2004; 191(6 Suppl 1):S82.
38. Howard WF, McFadden PR, Keettel WC. Oxytocic drugs in fourth stage of labor. JAMA 1964;189:411–3.
39. Huh W, Chelmow D, Malone FD. A randomized, double-blinded, placebo controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S130.
40. Irons DW, Sriskandabalan P, Bullough CH. A simple alternative to parenteral oxytocics for the third stage of labor. International Journal of Gynecology & Obstetrics 1994; 46:15–8.
41. Jackson KJ, Allbert J, Schemmer G, Elliot M, Humphrey A, Taylor J. A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage. American Journal of Obstetrics and Gynecology 2001;185:873–7.
42. Jans S, Herschderfer KC, van Diem MT, Aitink M, Rijnders M, van der Pal-Bruin K, et al. LENTE study: effectiveness of prophylactic intramuscular oxytocin during third stage of labour amongst low risk women. A randomized controlled trial. 31st International Confederation of Midwives Triennial Congress. Midwives-Making a Difference in the World; 2017 June 18-22; Toronto, Canada. 2017: Abstract no: P1.063.
43. Khan GQ, John IS, Chan T, Wani S, Doherty T. Controlled cord traction versus minimal intervention techniques in delivery of the placenta: a randomized controlled trial. American Journal of Obstetrics and Gynecology 1997;177(4): 770–4.
44. Kundodyiwa T, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. International Journal of Gynecology & Obstetrics 2001;75:235–41.
45. Lokugamage A, Paine M, Bassaw-Balroop K, Sullivan K, El-Refaey H, Rodeck C. Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon. Australian and New Zealand Journal of Obstetrics & Gynaecology 2001;41(4):411–4.
46. Lokugamage AU, Paine M, Bassau-Balroop H, El-Refaey K, Sullivan K, Rodek C. Active management of the third stage at caesarean section: misoprostol vs syntocinon. XVI FIGO World Congress of Obstetrics & Gynecology. 2000 Sept 3–8; Washington DC, USA 2000; Book 2:54.
47. Muller R, Beck G. Active management of the third stage of labour. 19th Swiss Congress of the Swiss Society of Gynecology and Obstetrics; 1996 June; Interlaken, Switzerland. 1996.
48. Neri-Mejia M, Pedraza-Aviles AG. Active management of the third stage of labor: three schemes of oxytocin: randomised clinical trial. Ginecologia y Obstetricia De Mexico 2016;84(5):306–13.
49. Newton M, Mosey LM, Egli GE, Gifford WB, Hull CT. Blood loss during and immediately after delivery. Obstetrics & Gynecology 1961;17:9–18.
50. Nieminen U, Jarvinen PA. A comparative study of different medical treatments of the third stage of labour. Annales Chirurgiae et Gynaecologiae Fenniae 1963;53:424–9.
51. Nuamsiri T, Kaewkiattikun K. Prevention of postpartum hemorrhage with oxytocin versus ergometrine plus oxytocin in the third stage of labor. Thai Journal of Obstetrics and Gynaecology 2016;24:97–103.
52. Nuamsiri T, TCTR20150820001. Prevention of postpartum hemorrhage with oxytocin versus ergometrine plus oxytocin in the third stage of labor. http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1& id=1508. (20 May 2015) 2015. TCTR20150820001]
53. Oguz Orhan E, Dilbaz B, Aksakal SE, Altinbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. International Journal of Gynecology and Obstetrics 2014;127(2):175–9.
54. Parsons S, Ntumy YM, Walley RL, Wilson JB, Crane JM, Matthews K, et al. Rectal misoprostol vs intramuscular oxytocin in the routine management of the third stage of labour. 30th British Congress of Obstetrics and Gynaecology; 2004 July 7-9; Glasgow, UK 2004;18. 2004.
55. Porter KB, O’Brien WF, Collins MK, Givens P, Knuppel R, Bruskivage L. A randomized comparison of umbilical vein and intravenous oxytocin during the puerperium. Obstetrics & Gynecology 1991;78:254–6.
56. Quibel T, Ghout I, Goffinet F, Salomon LJ, Fort J, Javoise S, et al. Active management of the third stage of labor with a combination of oxytocin and misoprostol to prevent postpartum hemorrhage: a randomized controlled trial. Obstetrics and Gynecology 2016;128(4):805–11.
57. Ramirez O, Benito V, Jimenez R, Valido C, Hernandez C, Garcia J. Third stage of labour: active or expectant management? preliminary results. Journal of Perinatal Medicine 2001;Suppl 1(Pt 2):364.
58. Rouse D, Abramovici A, Szychowski J, Seals S, Andrews W, Hauth J, et al. Oxytocin dose-regimens to prevent uterine atony after vaginal delivery: does treatment efficacy vary by risk status?. American Journal of Obstetrics and Gynecology 2011;204(1 Suppl):S50–S51.
59. Sariganont J. Comparative study between syntocinon and methergin in prevention of postpartum hemorrhage. Thai Journal of Obstetrics and Gynaecology 1999;11(4):248.
60. Schaefer A, Klein L, Wolfe P, Heindricks G, Downs L, Guinn D. Double blind rct of early versus traditional oxytocin management in the third stage to prevent blood loss. American Journal of Obstetrics and Gynecology 2004; 191(6 Suppl 1):S69.
61. Schemmer G. A randomized controlled trial comparing prophylactic administration of oxytocin before and after placental delivery in the prevention of postpartum hemorrhage [abstract]. American Journal of Obstetrics and Gynecology 2001;184(1):S20.
62. Sharma M, Kaur P, Kaur K, Kaur A, Kaur PK, Kaur MM. A comparative study of oxytocin/misoprostol/ methylergometrine for active management of the third stage of labor. Journal of Obstetrics and Gynecology of India 2014; 64(3):175–9.
63. Soiva K, Koistinen O. Clinical experience with simultaneous intramuscular injection of oxytocin and methylergometrine. Annales Chirurgiae et Gynaecologiae 1964;53:173–86.
64. Soriano D, Dulitzki M, Schiff E, Barkai G, Seldman DS. A randomized prospective trial of oxytocin plus ergometrin vs oxytocin alone for prevention of postpartum hemorrhage. American Journal of Obstetrics and Gynecology 1995;172: 361.
65. Stanton C, NCT01108302. Assessing the effectiveness, safety and feasibility of expanding use of oxytocin in uniject™ by auxiliary nurse midwives to prevent postpartum hemorrhage: a community-based cluster randomized trial in Bagalkot, India. clinicaltrials.gov/show/ NCT01108302 (first received 21 April 2010).
66. Stanton CK, Newton S, Mullany LC, Cofie P, Agyemang CT, Adiibokah E, et al. Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject by peripheral health care providers at home births: Design of a community-based cluster-randomized trial. BMC Pregnancy and Childbirth 2012;12:42.
67. Stanton C, NCT01108289. The oxytocin initiative: determining the effect of prophylactic administration of oxytocin in uniject™ by a community health officer on postpartum hemorrhage at home births in four districts in. clinicaltrials.gov/ct2/show/record/NCT01108289 (first received 21 April 2010).
68. Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C, Adiibokah E, et al. Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial. PLOS Medicine 2013;10 (10):e1001524.
69. Stearn RH. Syntometrine in the management of the third stage of labour. Journal of Obstetrics and Gynaecology of the British Commonwealth 1963;70:593–6.
70. Suhrabi Z, IRCT201304146790N6. Comparision the effect of dextrose and oxytocine on bleeding rate in 3th stage of labor in women who hospitalized in Shahid Mustafa Khomeini (PBUH) of Ilam city. en.irct.ir/trial/7202 (first received 26 May 2013).
71. Sunil Kumar KS, Shyam S, Batakurki P. Carboprost versus oxytocin for active management of third stage of labor: a prospective randomized control study. Journal of Obstetrics and Gynaecology of India 2016;66(Suppl 1):S229–34.
72. Symes JB. A study on the effect of ergometrine on serum prolactin levels following delivery. Journal of Obstetrics and Gynaecology 1984;5:36–8. Record 2022]
73. Tessier JL, Davies GAL, Woodman MC, Lipson A. Maternal hemodynamics after oxytocin bolus versus infusion in the third stage of labor. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S128.
74. Thornton S, Davison JM, Baylis PH. Plasma oxytocin during third stage of labour: comparison of natural and active management. BMJ 1988;297:167–9.
75. Tita A, NCT00790062. Comparison of the effectiveness of 3 different dose regimens of oxytocin in preventing uterine atony and postpartum hemorrhage during vaginal delivery. https://clinicaltrials.gov/show/NCT00790062 (first received 13 November 2008).
76. Tita AT, Szychowski JM, Rouse DJ, Bean CM, Chapman V, Nothern A, et al. Higher-dose oxytocin and hemorrhage after vaginal delivery: A randomized controlled trial. Obstetrics and Gynecology 2012;119(2 Pt 1):293–300.
77. Wetta L, Szychowski J, Seals S, Mancuso M, Hauth J, Tita A. Risk factors for uterine atony at vaginal delivery: a comprehensive evaluation. American Journal of Obstetrics and Gynecology 2011;204(1 Suppl):S71–2.
78. Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, Tita AT. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. American Journal of Obstetrics and Gynecology 2013;209(1): 51e1–6.
79. Vasegh FR, Bahiraie A, Mahmoudi M, Salehi L. Comparison of active and physiologic management of third stage of labor. HAYAT: Journal of Tehran Faculty of Nursing & Midwifery 2005;10(23):102.
80. Yuen PM, Chan NST, Yim SF, Chang AM. A randomised double blind comparison of Syntometrine and Syntocinon in the management of the third stage of labour. British Journal of Obstetrics and Gynaecology 1995;102:377–80.
81. Draycott T, NCT02216383. Intramuscular oxytocics: a comparison study of intramuscular carbetocin, syntocinon and syntometrine for the third stage of labour following vaginal birth. clinicaltrials.gov/ct2/show/record/ NCT02216383 (first received 15 August 2014).
82. Narenji F. Comparison the effect of intramuscular injection of oxytocin and nipple stimulation on the third stage of delivery length and bleeding. irct.ir/trial/10487 (first received 25 June 2012).
83. Shahbazian N, IRCT201106143756N2. Comparison of the effects of intramuscular methylergonovine, intravascular oxytocin, and sublingual prostaglandin (misoprostol) in active management of the third stage of labor. en.irct.ir/ trial/3866 (first received 20 September 2011).
84. Shahbazian N, Saadati N, Nezhad, Fathi L. Comparison of the effects of intramuscular methylergonovine, intravascular oxytocin, and sublingual misoprostol in active management of the third stage of labor. Jundishapur Scientific Medical Journal 2013;12(5):559–605.
85. Suthutvoravut S, TCTR20120000012. Comparison of postpartum blood loss between intravenous oxytocin and intravenous methylergometrine maleate during third stage of labor. clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1& id=741 (first received 5 August 2012).
86. Hermesch A, NCT02221830. Postpartum hemorrhage prevention in patients with preeclampsia (PHP3 Study). clinicaltrials.gov/ct2/show/record/NCT02221830 (first received 20 August 2014). NCT02221830]
87. Yogev Y, NCT02319707. Management of the third stage of labor. clinicaltrials.gov/ct2/show/NCT02319707 (first received 18 December 2014).
88. Al Kadri HM, Al Anazi BK, Tamim HM. Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study. Archives of Gynecology and Obstetrics 2011;283(6):1207–13.
89. Begley CM, Gyte GML, Devane D, McGuire W, Weeks A, Biesty LM. Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews 2019, Issue 2. DOI: 10.1002/14651858.CD007412.pub5
90. Borovac-Pinheiro A, Pacagnella RC, Cecatti JG, Miller S, El Ayadi AM, Souza JP, et al. Postpartum hemorrhage: new insights for definition and diagnosis. American Journal of Obstetrics and Gynecology 2018;219(2):162–8.
91. De Groot AN, Van Dongen PW, Vree TB, Hekster YA, Van Roosmalen J. Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynecology. Drugs 1998; 56(4):523–35.
92. Dildy GA, Paine AR, George NC, Velasco C. Estimating blood loss: can teaching significantly improve visual estimation?. Obstetrics and Gynecology 2004;104(3):601–6.
93. Du Vigneaud V, Ressler C, Tippet S. The sequence of amino acids in oxytocin with a proposal for the structure of oxytocin. Journal of Biological Chemistry 1953;205:949.
94. Embrey MP, Barber DT, Scudamore JH. Use of syntometrine in prevention of post partum haemorrhage. British Medical Journal 1963;1:1387–9.
95. Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database of Systematic Reviews 2018, Issue 12. DOI: 10.1002/14651858.CD011689.pub3
96. Higgins JP, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
97. Hoffman M, Castagnola D, Naqvi F. A randomized trial of active versus expectant management of the third stage of labor [abstract]. American Journal of Obstetrics and Gynecology 2006;195(6 Suppl 1):S107.
98. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, et al. Maternal mortality of 181 countries, 1980-2008: a systemic analysis of progress towards Millennium Development Goals 5. Lancet 2010;375 (9726):1609–23.
99. Kassebaum NJ, Barber RM, Bhutta ZA, Dandona L, Gething PW, Hay SI, et al. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1775–812.
100. Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database of Systematic Reviews 2018, Issue 6. DOI: 10.1002/14651858.CD005456.pub3
101. Meher S, Cuthbert A, Kirkham JJ, Williamson P, Abalos E, Aflaifel N, et al. Core outcome sets for prevention and treatment of postpartum hemorrhage: an international Delphi consensus study. British Journal of Obstetrics and Gynaecology 2018;126(1):83–93. DOI: 10.1111/1471-0528.15335
102. Moir JC. The action of ergot preparation on the puerperal uterus. British Medical Journal 1932;1:1119–22.
103. Moir JC. The history of present day use of ergot. Canadian Medical Association Journal 1955;72:727–34.
104. Mori R, Nardin JM, Yamamoto N, Carroli G, Weeks A. Umbilical vein injection for the routine management of third stage of labour. Cochrane Database of Systematic Reviews 2012, Issue 3. DOI: 10.1002/14651858.CD006176.pub2
105. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2015, Issue 6. DOI: 10.1002/14651858.CD007872.pub3
106. Pantoja T, Abalos E, Chapman E, Vera C, Serrano VP. Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings. Cochrane Database of Systematic Reviews 2016, Issue 4. DOI: 10.1002/14651858.CD011491.pub2
107. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
108. Say L, Chou D, Gemmill A, Tuncalp O, Moller A, Daniels J, et al. Global cause of maternal death: a WHO systematic analysis. Lancet 2014;2(6):e323–e333.
109. Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. American Journal of Obstetrics and Gynecology 2008;199(5):519.e1–7.
110. Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 4. DOI: 10.1002/14651858.CD005457.pub4
111. Toledo P, McCarthy RJ, Hewlett BJ, Fitzgerald PC, Wong CA. The accuracy of blood loss estimation after simulated vaginal delivery. Anesthesia Analgesia 2007;105(6):1736–40.
112. Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2012, Issue 8. DOI: 10.1002/14651858.CD000494.pub4
113. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. https://apps.who.int/iris/bitstream/handle/10665/75411/9789241548502eng.pdf;sequence=1. Geneva: World Health Organization, (date accessed 27 August 2018).
114. World Health Organization. WHO recommendations for the prevention of postpartum haemorrhage. https://afro.who.int/sites/default/files/2017-06/WHO MPS 0706 engPPH.pdf. Geneva: World Health Organization, (accessed 1 February 2019).
115. Cotter AM, Ness A, Tolosa JE. Prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews 2001, Issue 4. DOI: 10.1002/14651858.CD001808
116. Elbourne D, Prendiville W, Chalmers I. Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1988;95 (1):17–30.
117. Prendiville W, Elbourne D, Chalmers I. The effect of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. British Journal of Obstetrics and Gynaecology 1988;95(1):3–16.
118. Prendiville WJ, Elbourne DR. Care during the third stage of labour. In: Chalmers I, Enkin M, Keirse MJNC editor(s). Effective Care in Pregnancy and Childbirth. Vol. 2, Oxford: Oxford University Press, 1989:1145–69.
119. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database of Systematic Reviews 2013, Issue 10. DOI: 10.1002/14651858.CD001808.pub2